49 Wealth Management LLC purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,956 shares of the company’s stock, valued at approximately $1,151,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Frazier Financial Advisors LLC bought a new stake in Merck KGaA during the 2nd quarter valued at approximately $25,000. Rakuten Securities Inc. bought a new stake in shares of Merck KGaA in the 2nd quarter worth about $27,000. Solstein Capital LLC bought a new stake in Merck KGaA during the second quarter worth approximately $33,000. Delos Wealth Advisors LLC purchased a new stake in Merck KGaA during the second quarter valued at approximately $33,000. Finally, Burk Holdings LLC bought a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $39,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Up 3.8%
Shares of MKGAF opened at $164.12 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The business has a fifty day moving average of $163.35 and a 200 day moving average of $149.06. The company has a market cap of $21.21 billion, a PE ratio of 25.06 and a beta of 0.96. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
